News room

PledPharma in the media

Redeye research, April 30, 2020

Pledpharma: Aladote upside

World of Gastrointestinal Oncology, Feb 17 2020

Neuropathy experienced by colorectal cancer patients receiving oxaliplatin

Interview with Mr Akschuti, analyst at Pareto Securities, Feb 6 2020

Pareto Securities equity analyst elaborates on the US clinical hold for the POLAR-M study.

Läkemedelsvärlden, December 14, 2020 (in Swedish)

Increasing number of cases with acetaminophen overdose in Sweden.

The independent financial news site EFN, Dec 9 2019

PledPharma mentioned on EFN as one of the Swedish healthcare companies to keep an eye on. The discussion in English starts 5 min 30 sec into the program.

Liver Research

“Thus, if efficacy in high overdose patients can be established, calmangafodipir may be a promising complementary antidote to NAC.” Oct 2019

Jaeschke H, Duan L, Nguyen N, Ramachandran A, Mitochondrial damage and biogenesis in acetaminophen-induced liver injury, Liver Research

Svd Näringsliv 19 januari 2019 (in Swedish)

PledPharma: Håller nerverna i styr genom studietider
Keeps their nerves in control through the study

Calendar and upcoming reports

November 11, 2020
Interim report third quarter 2020

October 28, 2020
Extrodinary general meeting

Show more events



Contact us

Address: Grev Turegatan 11 C, 114 46 Stockholm, Sweden

Phone: +46 8 679 72 10